
Sign up to save your podcasts
Or
It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.
4.7
9292 ratings
It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.
137 Listeners
702 Listeners
500 Listeners
289 Listeners
286 Listeners
263 Listeners
3,341 Listeners
1,150 Listeners
191 Listeners
88 Listeners
514 Listeners
368 Listeners
249 Listeners
372 Listeners
315 Listeners